BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37429610)

  • 1. RUSC1-AS1 promotes the malignant progression of breast cancer depending on the regulation of the miR-326/XRCC5 pathway.
    Ayoufu A; Paierhati P; Qiao L; Zhang N; Abudukeremu M
    Thorac Cancer; 2023 Aug; 14(24):2504-2514. PubMed ID: 37429610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA
    Guo Q; Zhang Q; Lu L; Xu Y
    Cell Cycle; 2020 May; 19(10):1222-1235. PubMed ID: 32264732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA RUSC1-AS1 promotes the proliferation of hepatocellular carcinoma cells through modulating NOTCH signaling.
    Chen YA; Cheng L; Zhang Y; Peng L; Yang HG
    Neoplasma; 2020 Nov; 67(6):1204-1213. PubMed ID: 32701359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway.
    Tong CJ; Deng QC; Ou DJ; Long X; Liu H; Huang K
    Aging (Albany NY); 2021 May; 13(16):20116-20130. PubMed ID: 34048366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA RUSC1-AS1 promotes the proliferation of breast cancer cells by epigenetic silence of KLF2 and CDKN1A.
    Hu CC; Liang YW; Hu JL; Liu LF; Liang JW; Wang R
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6602-6611. PubMed ID: 31378902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis.
    Ding Y; Huang Y; Zhang F; Gong L; Liang C; Ding K; He X; Ding X; Chen Y
    J Transl Med; 2023 Nov; 21(1):854. PubMed ID: 38008726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA ZBED3-AS1 restrains breast cancer progression by targeting the microRNA-513a-5p/KLF6 axis.
    Fu A; Yu Z; Zhang E; Song J
    Thorac Cancer; 2021 Oct; 12(20):2719-2731. PubMed ID: 34427978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
    Yang J; Wu W; Wu M; Ding J
    In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in Breast Cancer via miR-933/SMAD2.
    Zhou B; Guo H; Tang J
    Med Sci Monit; 2019 Feb; 25():1242-1253. PubMed ID: 30768589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA A1BG-AS1 promotes tumorigenesis in breast cancer by sponging microRNA-485-5p and consequently increasing expression of FLOT1 expression.
    Cai S; Zhou Y; Pan Y; Liu P; Yu K; Chen S
    Hum Cell; 2021 Sep; 34(5):1517-1531. PubMed ID: 34115333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
    Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
    J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
    Qiao Y; Wang B; Yan Y; Niu L
    Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of
    Meng Q; Wang L; Lv Y; Wu J; Shi W
    Cancer Biother Radiopharm; 2021 Feb; 36(1):23-35. PubMed ID: 32319789
    [No Abstract]   [Full Text] [Related]  

  • 15. lncRNA CERS6-AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR-125a-5p to upregulate BAP1 expression.
    Yan L; Li K; Feng Z; Zhang Y; Han R; Ma J; Zhang J; Wu X; Liu H; Jiang Y; Zhang Y; Zhu Y
    Mol Carcinog; 2020 Oct; 59(10):1199-1208. PubMed ID: 32808708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA DSCAM-AS1 acts as a sponge of miR-137 to enhance Tamoxifen resistance in breast cancer.
    Ma Y; Bu D; Long J; Chai W; Dong J
    J Cell Physiol; 2019 Mar; 234(3):2880-2894. PubMed ID: 30203615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA regulatory factor X3- antisense RNA 1 promotes non-small cell lung cancer via the microRNA-577/signal transducer and activator of transcription 3 axis.
    Hu Y; Zhao Z; Jin G; Guo J; Nan F; Hu X; Hu Y; Han Q
    Bioengineered; 2022 Apr; 13(4):10749-10764. PubMed ID: 35475457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA
    Chen D; Chen J; Gao J; Zhang Y; Ma Y; Wei W; Wei Y
    Cancer Biother Radiopharm; 2020 Jun; 35(5):319-328. PubMed ID: 32412777
    [No Abstract]   [Full Text] [Related]  

  • 19. Long Noncoding RNA
    Yao L; Chen L; Zhou H; Duan F; Wang L; Zhang Y
    Cancer Biother Radiopharm; 2022 Oct; 37(8):636-649. PubMed ID: 32833504
    [No Abstract]   [Full Text] [Related]  

  • 20. LncRNA RUSC1-AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR-340-5p/CREB1 axis.
    Liu C; Tang L; Xu M; Lin Y; Shen J; Zhou L; Ho L; Lu J; Ai X
    Am J Transl Res; 2021; 13(3):1022-1036. PubMed ID: 33841637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.